Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
December 20, 2021 16:05 ET
|
Progenity, Inc.
SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
Progenity Announces New Patent for Single-Molecule Detection Technology
December 02, 2021 06:30 ET
|
Progenity, Inc.
SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a...
Progenity Strengthens its Liquidity Position
November 23, 2021 06:30 ET
|
Progenity, Inc.
Company received more than $44 million in warrant exercises since August 2021. Current liquidity position provides runway to achieve critical research and development milestones through 2022. SAN...
Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 15, 2021 06:30 ET
|
Progenity, Inc.
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at...
Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results
November 10, 2021 16:01 ET
|
Progenity, Inc.
Added important patents further protecting the company’s therapeutic delivery technologiesAdded strong biotherapeutics capabilities to management team and board of directorsImplemented cost-cutting...
Progenity Appoints Adi Mohanty as Chief Executive Officer
November 09, 2021 06:30 ET
|
Progenity, Inc.
SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Adi Mohanty as Chief Executive Officer of the...
Progenity Announces Appointment of Jill Howe to its Board of Directors
November 04, 2021 06:30 ET
|
Progenity, Inc.
SAN DIEGO, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced the appointment of Jill Howe to its board of directors effective November...
Progenity to Report Third Quarter 2021 Financial Results and Provide Corporate Update
November 03, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), an innovative biotechnology company, today announced that it will report third quarter 2021 financial results on...
Progenity Reduces Outstanding Debt by $20.175 Million Through a Private Exchange of $20.175 Million of Its 7.25% Convertible Senior Notes Due 2025 for Shares of Common Stock
October 26, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into privately negotiated...
Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Ingestible Therapeutics Technologies
October 13, 2021 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has...